4399在线视频免费观看

山(shan)東(dong)泰(tai)邦(bang)生(sheng)(sheng)(sheng)(sheng)物(wu)(wu)制(zhi)品(pin)(pin)(pin)(pin)有(you)(you)限公(gong)(gong)(gong)司簡介山(shan)東(dong)泰(tai)邦(bang)生(sheng)(sheng)(sheng)(sheng)物(wu)(wu)制(zhi)品(pin)(pin)(pin)(pin)有(you)(you)限公(gong)(gong)(gong)司是在山(shan)東(dong)省(sheng)生(sheng)(sheng)(sheng)(sheng)物(wu)(wu)制(zhi)品(pin)(pin)(pin)(pin)研究(jiu)所(suo)與(yu)外商于二(er)00二(er)年十一(yi)月成立的(de)(de)(de)(de)合(he)資(zi)企業。是以(yi)血液(ye)制(zhi)品(pin)(pin)(pin)(pin)、基因(yin)工程(cheng)產品(pin)(pin)(pin)(pin)和生(sheng)(sheng)(sheng)(sheng)化制(zhi)藥為(wei)主體的(de)(de)(de)(de),集科研、生(sheng)(sheng)(sheng)(sheng)產、經(jing)營一(yi)體化的(de)(de)(de)(de)重點高新(xin)技術(shu)企業。是山(shan)東(dong)定點的(de)(de)(de)(de)國(guo)(guo)家(jia)血液(ye)制(zhi)品(pin)(pin)(pin)(pin)生(sheng)(sheng)(sheng)(sheng)產企業。公(gong)(gong)(gong)司總部設在山(shan)東(dong)泰(tai)安。在泰(tai)安建有(you)(you)一(yi)個血液(ye)制(zhi)品(pin)(pin)(pin)(pin)生(sheng)(sheng)(sheng)(sheng)產基地和血液(ye)制(zhi)品(pin)(pin)(pin)(pin)研究(jiu)中(zhong)心。公(gong)(gong)(gong)司現有(you)(you)人血白(bai)(bai)蛋(dan)白(bai)(bai)、人免疫(yi)球(qiu)(qiu)蛋(dan)白(bai)(bai)、靜注人免疫(yi)球(qiu)(qiu)蛋(dan)白(bai)(bai)（pH4）、乙(yi)型肝(gan)炎人免疫(yi)球(qiu)(qiu)蛋(dan)白(bai)(bai)、狂犬病人免疫(yi)球(qiu)(qiu)蛋(dan)白(bai)(bai)、破(po)傷風人免疫(yi)球(qiu)(qiu)蛋(dan)白(bai)(bai)、人凝(ning)血因(yin)子Ⅷ、人凝(ning)血酶原(yuan)復(fu)合(he)物(wu)(wu)、人纖(xian)維蛋(dan)白(bai)(bai)原(yuan)等(deng)(deng)9個品(pin)(pin)(pin)(pin)種，24個規格的(de)(de)(de)(de)產品(pin)(pin)(pin)(pin)，產品(pin)(pin)(pin)(pin)批(pi)簽發(fa)合(he)格率(lv)100%，優質的(de)(de)(de)(de)產品(pin)(pin)(pin)(pin)贏得(de)了(le)市(shi)場的(de)(de)(de)(de)青睞。合(he)資(zi)以(yi)來(lai)，銷售收入年增長(chang)率(lv)超(chao)過(guo)50%。泰(tai)邦(bang)生(sheng)(sheng)(sheng)(sheng)物(wu)(wu)成立六年來(lai),生(sheng)(sheng)(sheng)(sheng)產經(jing)營迅(xun)速擴(kuo)大(da)(da),經(jing)濟取得(de)長(chang)足發(fa)展(zhan)。企業的(de)(de)(de)(de)綜(zong)合(he)實力從(cong)最初的(de)(de)(de)(de)血液(ye)制(zhi)品(pin)(pin)(pin)(pin)行(xing)業第三梯(ti)隊(dui)(dui)上升為(wei)第一(yi)梯(ti)隊(dui)(dui)，產值利潤(run)等(deng)(deng)各項經(jing)濟指標統計(ji)的(de)(de)(de)(de)綜(zong)合(he)實力排名,去年居(ju)全國(guo)(guo)血液(ye)制(zhi)品(pin)(pin)(pin)(pin)同行(xing)業位列前3位。目前，公(gong)(gong)(gong)司擁有(you)(you)一(yi)支國(guo)(guo)際化的(de)(de)(de)(de)管理團隊(dui)(dui)，其中(zhong)境外高管人士近(jin)半數，建立起(qi)了(le)與(yu)國(guo)(guo)際化運作相適應的(de)(de)(de)(de)管理隊(dui)(dui)伍(wu)。2009年12月公(gong)(gong)(gong)司控(kong)股股東(dong)—China Biologic Products, Inc.（中(zhong)國(guo)(guo)生(sheng)(sheng)(sheng)(sheng)物(wu)(wu)制(zhi)品(pin)(pin)(pin)(pin)）于美(mei)國(guo)(guo)納斯達克成功上市(shi)（交易代碼為(wei)NASDAQ:CBPO），為(wei)公(gong)(gong)(gong)司的(de)(de)(de)(de)發(fa)展(zhan)提供了(le)強大(da)(da)的(de)(de)(de)(de)資(zi)本支持， 2009年9月，中(zhong)國(guo)(guo)生(sheng)(sheng)(sheng)(sheng)物(wu)(wu)制(zhi)品(pin)(pin)(pin)(pin)從(cong)12000多(duo)家(jia)候(hou)選上市(shi)公(gong)(gong)(gong)司中(zhong)脫穎(ying)而出，榮登《福布斯》公(gong)(gong)(gong)布2009亞洲200家(jia)中(zhong)小企業榜單。